Vicarious Surgical Inc. (NYSE:RBOT) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET

Company Participants

Kaitlyn Brosco - Head, Investor Relations
Adam Sachs - Co-Founder and CEO
Bill Kelly - Chief Financial Officer
Randy Clark - President

Conference Call Participants

Ryan Zimmerman - BTIG
Adam Maeder - Piper Sandler
Josh Jennings - TD Cowen

Operator

Hello. And welcome to Vicarious Surgical’s 2024 First Quarter Earnings Call. My name is Elliot, and I’ll be coordinating your call today. [Operator Instructions]

I’d now like to hand over to Kaitlyn Brosco, Head of Investor Relations. The floor is yours. Please go ahead.

Kaitlyn Brosco

Thanks Elliot, and thank you all for joining. With me today for prepared remarks are Adam Sachs, Co-Founder and Chief Executive Officer; and Bill Kelly, Chief Financial Officer. Later, Randy Clark, our new company President, will join for the Q&A portion of this call.

Today after market closed, Vicarious Surgical released financial results for the three months ended March 31, 2024. A copy of this press release is available on the company website.

Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including without limitation, those relating to obtaining approval for the Vicarious Surgical system and timing for any such approval, our operating trends and future financial performance, expense management, market opportunity and commercialization are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that would cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place any undue reliance on these statements.

For a list and description of the risks and uncertainties associated with the business, please refer to the risk factors set forth in our Securities and Exchange Commission filings, including our most recent Form 10-K and Form 10-Q.

This conference call contains time-sensitive information and is accurate only of this live broadcast today, April 29, 2024. Vicarious Surgical disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.